نتایج جستجو برای: autologous stem cell transplantation

تعداد نتایج: 1901562  

Ali Khakshour, Foad Faroughi, Habibolah Taghizadeh Moghadam Majid Rahban Masumeh Saeidi

Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. They are found in multicellular organisms. In mammals, there are two broad types of stem cells: embryonic stem cells, which are isolated from the inner cell mass of blastocysts, and adult stem cells, which are found in various tissues. In ad...

Journal: :the journal of tehran university heart center 0
seyed mahdi nassiri department of clinical pathology, faculty of veterinary medicine, university of tehran, tehran, iran seyed hossein ahmadi tehran heart center, medical sciences / university of tehran, tehran, iran. zohreh khaki department of clinical pathology, faculty of veterinary medicine, university of tehran, tehran, iran masoud soleimani department of hematology, school of medical sciences, tarbiat modares university, tehran, iran. issa jahanzad department of pathology, imam khomeini hospital complex, medical sciences / university of tehran, te shahram rabbani tehran heart center, medical sciences / university of tehran, tehran, iran.

background: marrow-derived mesenchymal stem cells (mscs) have been heralded as a source of great promise for the regeneration of the infarcted heart. there are no clear data as to whether or not in vitro differentiation of mscs into major myocardial cells can increase the beneficial effects of mscs. the aim of this study was to address this issue. methods: to induce mscs to transdifferentiate i...

Journal: :international journal of hematology-oncology and stem cell research 0
saeed mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ashraf malek mohammadi hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran mohsen nikbakht hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran amir hossein norooznezhad hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran kamran alimoghaddam hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran ardeshir ghavamzadeh hematology-oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran

peripheral blood stem cell transplantation (pbsct) is an effective treatment for hematological malignancies. mobilization of peripheral blood progenitor cells performs in different ways among transplantation centers. forceful mobilization schedules are comprised of growth factor alone, chemotherapy along with growth factor and also, a newly combination of novel agent such as plerixafor with any...

Journal: :international journal of pediatrics 0
daryoush hamidi alamdari stem cell and regenerative medicine research group, department of biochemistry, faculty of medicine, mashhad university of medical sciences, mashhad, iran. farzaneh sharifipour transaplant department, imam reza hospital, mashhad university of medical sciences, mashhad, iran. hassan ravari mashhad vascular and endovascular surgery research center, imam reza hospital, mashhad university of medical sciences, mashhad, iran. fereshteh mamdouhi transaplant department, imam reza hospital, mashhad university of medical sciences, mashhad, iran. massih naghibi transaplant department, imam reza hospital, mashhad university of medical sciences, mashhad, iran. maryam hami transaplant department, imam reza hospital, mashhad university of medical sciences, mashhad, iran.

background:  renal transplantation is the best choose in the end stage renal disease (esrd), and acute rejection and graft dysfunction remain major challenges in the worldwide, even with the advent of new immunosuppressive drugs. the novel cell-based anti-rejection treatments have been studied by using different stem cell sources. in this study, transplantation of autologous-bone-marrow-derived...

2015
Tianmei Zeng Lili Zhou Hao Xi Weijun Fu Juan Du Chunyang Zhang Hua Jiang Jian Hou

Aim. To evaluate whether patients with multiple myeloma at various risks can still benefit the same from autologous stem cell transplantation consolidation in the era of novel agents. We retrospectively analyzed 67 consecutive myeloma patients receiving autologous stem cell transplantation after bortezomib and/or thalidomide based inductions. Totally 17 high-risk, 24 intermediate-risk, and 26 l...

Journal: :iranian red crescent medical journal 0
ardeshir ghavamzadeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran kamran alimoghaddam hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran; hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran. email: fatemeh ghaffari hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran roshanak derakhshandeh hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran arash jalali hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran mohammad jahani hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, ir iran

conclusions in iran, hsct has been successfully adapted in routine clinical care. recently, new methods such as double cord blood and haploidentical transplantation have been used to treat many life-threatening diseases. results about 78.2% of the patients (2530 of 3237) remained alive between one to 211 months after stem cell transplantation. nearly, 21.8% (707) of our patients died after stem...

Ali Eshraghi Ali Ghasemi, Arash Gholobi Farveh Vakilian Fereshte Ghaderi Hoda Madani Hoorak Poorzand Javad Ramezani Mahmood M. Shabestari Maryam Salehi Mohamad Vejdanparast Sara Amini Toktam Moghiman

Introduction: We aimed at evaluating the clinical, laboratory and echocardiography effects of intracoronary administration of autologous bone marrow stem cell transplantation in different clinical entities of chronic Heart Failure (HF) patients.   Methods: This procedure was carried out during an interventional study conducted in the Cardiology department from JAN 2012 to APR 2013. The HF ...

Ali Ghasemi, Farhad Gholami Freshteh Mamdouh

Background Chronic allograft nephropathy(CAN)  is one of the most common causes of chronic and end stage renal disease. It  is defined with Mainly tubular atrophy and  interstitial fibrosis and no evidence of any other etiology, or functional disorder that caused at least three months after transplantation . Control of risk factors (HTN,DM,HLP, …) and limiting  usage of calcineurin inhibitors...

Journal: :international journal of pediatrics 0
ali ghasemi assistant professor , hematologist&oncologist, montaserie hospital, mashhad university of medical sciences, mashhad, iran. freshteh mamdouh assistant professor , nephrologist, montaserie hospital, mashhad university of medical sciences, mashhad, iran. farhad gholami assistant of nephrology, montaserie hospital, mashhad university of medical sciences, mashhad, iran.

background chronic allograft nephropathy(can)  is one of the most common causes of chronic and end stage renal disease. it  is defined with mainly tubular atrophy and  interstitial fibrosis and no evidence of any other etiology, or functional disorder that caused at least three months after transplantation . control of risk factors (htn,dm,hlp, …) and limiting  usage of calcineurin inhibitors o...

Journal: :Haematologica 2017
Gordon Cook Simona Iacobelli Anja van Biezen Dimitris Ziagkos Veronique LeBlond Julie Abraham Grant McQuaker Stefan Schoenland Alessandro Rambaldi Kazimierz Halaburda Maria Rovira Simona Sica Jenny Byrne Ramon Garcia Sanz Arnon Nagler Niels W C J van de Donk Marjatta Sinisalo Mark Cook Nicolaus Kröger Theo De Witte Curly Morris Laurant Garderet

POEMS syndrome is a rare para-neoplastic syndrome secondary to a plasma cell dyscrasia. Effective treatment can control the disease-related symptom complex. We describe the clinical outcome of autologous stem cell transplantation for patients with POEMS syndrome, determining the impact of patient- and disease-specific factors on prognosis. One hundred and twenty-seven patients underwent an auto...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید